Evidence map›Paper›PMID 39073768›Full record

Observational studyCardiovascular research2024

Coronavirus disease 2019-related myocardial injury is associated with immune dysregulation in symptomatic patients with cardiac magnetic resonance imaging abnormalities.

Andrej Ćorović, Xiaohui Zhao, Yuan Huang, Stephen R Newland, Deepa Gopalan, James Harrison, Despina Giakomidi, Shanna Chen, Natalia S Yarkoni, Christopher Wall and 13 more

Abstract readObservational Study
In one paragraph

Observational study in Cardiovascular research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Andrej ĆorovićSection of Cardiorespiratory Medicine, Department of Medicine, University of Cambridge, Cambridge, UK.
Xiaohui ZhaoSection of Cardiorespiratory Medicine, Department of Medicine, University of Cambridge, Cambridge, UK.
Yuan HuangSection of Cardiorespiratory Medicine, Department of Medicine, University of Cambridge, Cambridge, UK.
Stephen R NewlandSection of Cardiorespiratory Medicine, Department of Medicine, University of Cambridge, Cambridge, UK.
Deepa GopalanDepartment of Radiology, Cambridge University Hospitals NHS Trust, Cambridge, UK.ORCID 0000-0001-8079-205X
James HarrisonSection of Cardiorespiratory Medicine, Department of Medicine, University of Cambridge, Cambridge, UK.
Despina GiakomidiSection of Cardiorespiratory Medicine, Department of Medicine, University of Cambridge, Cambridge, UK.
Shanna ChenSection of Cardiorespiratory Medicine, Department of Medicine, University of Cambridge, Cambridge, UK.
Natalia S YarkoniCell Phenotyping Hub, Department of Medicine, University of Cambridge, Cambridge, UK.
Christopher WallSection of Cardiorespiratory Medicine, Department of Medicine, University of Cambridge, Cambridge, UK.
Marta PeverelliSection of Cardiorespiratory Medicine, Department of Medicine, University of Cambridge, Cambridge, UK.
Rouchelle SriranjanSection of Cardiorespiratory Medicine, Department of Medicine, University of Cambridge, Cambridge, UK.
Arianna GalloSection of Cardiorespiratory Medicine, Department of Medicine, University of Cambridge, Cambridge, UK.
Martin J GravesDepartment of Radiology, University of Cambridge, Cambridge, UK.
Andrew SageSection of Cardiorespiratory Medicine, Department of Medicine, University of Cambridge, Cambridge, UK.
Paul A LyonsCambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.
Nyarie SitholeInfectious Diseases, Department of Medicine, University of Cambridge, Cambridge, UK.
Martin R BennettSection of Cardiorespiratory Medicine, Department of Medicine, University of Cambridge, Cambridge, UK.
James H F RuddSection of Cardiorespiratory Medicine, Department of Medicine, University of Cambridge, Cambridge, UK.
Ziad MallatSection of Cardiorespiratory Medicine, Department of Medicine, University of Cambridge, Cambridge, UK.
Tian X ZhaoSection of Cardiorespiratory Medicine, Department of Medicine, University of Cambridge, Cambridge, UK.
Meritxell NusSection of Cardiorespiratory Medicine, Department of Medicine, University of Cambridge, Cambridge, UK.ORCID 0000-0002-6378-8910
Jason M TarkinSection of Cardiorespiratory Medicine, Department of Medicine, University of Cambridge, Cambridge, UK.ORCID 0000-0002-9132-120X

Funding

(BHF) Centre of Research Excellence 18/1/34212British Heart Foundation CH/2000003/12800Cambridge British Heart FoundationWellcome Trust
6 · The paper itself

Abstract

aimsWhile acute cardiovascular complications of coronavirus disease 2019 (COVID-19) are well described, less is known about longer-term cardiac sequelae. For many individuals with cardiac signs or symptoms arising after COVID-19 infection, the aetiology remains unclear. We examined immune profiles associated with magnetic resonance imaging (MRI) abnormalities in patients with unexplained cardiac injury after COVID-19. METHODS AND

resultsTwenty-one participants {mean age 47 [standard deviation (SD) 13] years, 71% female} with long COVID-19 (n = 17), raised troponin (n = 2), or unexplained new-onset heart failure (n = 2), who did not have pre-existing heart conditions or recent steroid/immunosuppression treatment, were enrolled a mean 346 (SD 191) days after COVID-19 infection in a prospective observational study. Cardiac MRI and blood sampling for deep immunophenotyping using mass cytometry by time of flight and measurement of proteomic inflammatory markers were performed. Nine of the 21 (43%) participants had MRI abnormalities (MRI(+)), including non-ischaemic patterns of late gadolinium enhancement and/or visually overt myocardial oedema in 8 people. One patient had mildly impaired biventricular function without fibrosis or oedema, and two had severe left ventricular (LV) impairment. MRI(+) individuals had higher blood CCL3, CCL7, FGF-23, and CD4 Th2 cells, and lower CD8 T effector memory (TEM) cells, than MRI(-). Cluster analysis revealed lower expression of inhibitory receptors PD1 and TIM3 in CD8 TEM cells from MRI(+) patients than MRI(-) patients, and functional studies of CD8 T αβ cells showed higher proportions of cytotoxic granzyme B+(GZB+)-secreting cells upon stimulation. CD8 TEM cells and CCL7 were the strongest predictors of MRI abnormalities in a least absolute shrinkage and selection operator regression model (composite area under the curve 0.96, 95% confidence interval 0.88-1.0). CCL7 was correlated with diffuse myocardial fibrosis/oedema detected by quantitative T1 mapping (r = 0.47, P = 0.04).

conclusionCOVID-19-related cardiac injury in symptomatic patients with non-ischaemic myocarditis-like MRI abnormalities is associated with immune dysregulation, including decreased peripheral CD8 TEM cells and increased CCL7, persisting long after the initial infection.

Indexed as

COVID-19Magnetic Resonance ImagingAdultAgedCD8-Positive T-LymphocytesEdema, CardiacFemaleHumansMaleMiddle AgedMyocardiumPredictive Value of TestsProspective StudiesSARS-CoV-2COVID-19ImmunophenotypingMagnetic resonance imagingMyocarditis

Identifiers

PMID39073768
PMCPMC11587552

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.